Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden

PURPOSE: Introduction of the direct-acting antivirals (DAAs) for treatment of chronic hepatitis C (CHC) infection has been challenging in all health systems. In Sweden, a national protocol for managed introduction was developed. It was optional, but all county councils agreed to implement and follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Frisk, P., Aggefors, K., Cars, T., Feltelius, N., Loov, S. A., Wettermark, B., Weiland, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999144/
https://www.ncbi.nlm.nih.gov/pubmed/29632961
http://dx.doi.org/10.1007/s00228-018-2456-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999144/
https://www.ncbi.nlm.nih.gov/pubmed/29632961
http://dx.doi.org/10.1007/s00228-018-2456-y

Ejemplares similares